Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.
about
Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific mannerMolecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankindEvolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groupsHeparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.Loss of robustness and addiction to IGF1 during early keratinocyte transformation by human Papilloma virus 16Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprintingRetinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cellsDirect binding of AP-1 (Fos/Jun) proteins to a SMAD binding element facilitates both gonadotropin-releasing hormone (GnRH)- and activin-mediated transcriptional activation of the mouse GnRH receptor gene.The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction.Isolation of three novel rat and mouse papillomaviruses and their genomic characterizationA novel archaeal regulatory protein, Sta1, activates transcription from viral promoters.Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers.Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells.During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.The constitutively expressed octamer binding protein OTF-1 and a novel octamer binding protein expressed specifically in cervical cells bind to an octamer-related sequence in the human papillomavirus 16 enhancer.Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated.Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNAE5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding elementTranscription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.Identification of an enhancer involved in the melanoma-specific expression of the tumor antigen melanotransferrin gene.Post-Transcriptional Regulation of KLF4 by High-Risk Human Papillomaviruses Is Necessary for the Differentiation-Dependent Viral Life Cycle.Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.Keratinocyte growth factor is a bifunctional regulator of HPV16 DNA-immortalized cervical epithelial cellsVariation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world.Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16Cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region in transgenic mice and its modulation by tetradecanoyl phorbol acetate and glucocorticoids.Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long cLate promoter of human papillomavirus type 8 and its regulation.Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomesTransforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells.A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter.The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription.NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.NFI is an essential positive transcription factor for human papillomavirus type 16 early gene expressionSequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic treePCR analysis of the upstream regulatory region of human papillomavirus genomes in cervical intraepithelial neoplasia and cervical carcinoma.A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells.The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.
P2860
Q24324627-12F16985-E9B6-4201-ABD6-DA5F113D806FQ28776617-38A88C9F-2C40-4C1F-8A8B-B75B130CBBE2Q28776761-BD271E0F-A884-4EFF-8793-AE632BD4ACDAQ33255972-62B403A6-8061-4123-9112-924B0AC6F407Q33290438-22A3DE68-F97D-45A5-B75B-016E53F45489Q33782147-52551F49-F3F9-4149-AED4-AE3C537C1AC0Q33937895-ED58DFB2-343E-4B04-AAC5-25E3F9EA1996Q34141578-A3C4FFA2-ABA1-44F5-905E-EDF37A9EE93AQ34346765-F807C88E-F070-4DC8-A06B-9A1F46A4BBEDQ34450609-CB133D7A-7F06-4606-B317-AB358F6EBD82Q34566255-9D9D0B9F-F5A2-48EE-B734-3EA3E02FF42DQ34813512-4B635622-7409-4440-83E3-3AFDDE6EDB27Q34995160-39E1BD0A-74DB-44E4-B8DB-3C965AE4C219Q35011943-43B2EC80-AD41-4025-960F-1AD47CE60FB4Q35777389-75344D63-04BE-4D4F-89AE-BC25508547A0Q35804675-8B840761-150D-4639-8181-07DAC043466CQ35858861-7E1EF9C7-055C-4075-8D50-5AA05799BDEFQ35873508-50083EA2-75B2-4987-AD18-969FA80B8236Q35899069-1088C040-AA4C-4C2F-ABFE-7563094FD203Q35938965-01152798-4DE4-4A2A-B0E5-F481EDC2AB60Q36014157-AD002920-56D7-41C4-B750-2539FA14497CQ36069580-DA533942-26D4-4500-87BA-7EA63F1DBD93Q36080863-929F9741-6523-4F1D-BE64-B0445F4963CCQ36235568-A282A7CA-4C7E-4F17-9E3E-44522ACF3A88Q36523157-B24FCFF3-4A9A-4312-9FED-36040B3CB954Q36650759-749B15A6-7EFC-4395-8E29-0DBC2665AF5CQ36654533-7EF4BD8E-AEE4-4289-9CA1-F499C25338FFQ36684327-59C4024E-26B9-4D31-990B-7C4CDF10E59EQ36697994-3B6E09BE-9972-4620-9ADC-897830A117F5Q36702325-287FD652-7BA0-4812-B7AB-905BFBEB8D63Q36783874-8DED07B8-837A-4421-A6B9-D7E637328AC5Q36783926-8D80B51A-364B-4D7C-B102-EED08EC7CE71Q36793464-06CA8C87-5020-47D5-863C-F7EA5C5FDF42Q36820980-9FFB41AF-9DF5-4115-8FCF-013ADD61A86AQ37093403-3BD3C1E8-52C5-49F2-A8CD-908DFF03ED6FQ37175161-989AC6BF-1C0A-4203-B38D-43C59F7A24A9Q37241876-CC511A95-547C-4849-8A65-8761A9683356Q37243544-BF89CD08-90E7-427C-9E62-8273C9491CA1Q37606041-1C9A8C25-BFD1-44D3-9F6A-6CFC75C83976Q37630368-725C66A9-5D1E-45BA-9B09-30589FC80E7C
P2860
Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Transcriptional activation of ...... ital papillomavirus enhancers.
@ast
Transcriptional activation of ...... ital papillomavirus enhancers.
@en
type
label
Transcriptional activation of ...... ital papillomavirus enhancers.
@ast
Transcriptional activation of ...... ital papillomavirus enhancers.
@en
prefLabel
Transcriptional activation of ...... ital papillomavirus enhancers.
@ast
Transcriptional activation of ...... ital papillomavirus enhancers.
@en
P2093
P2860
P356
P1476
Transcriptional activation of ...... ital papillomavirus enhancers.
@en
P2093
P2860
P304
P356
10.1093/NAR/18.3.465
P407
P577
1990-02-01T00:00:00Z